Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with treating osteoarthritis
1 finding from 1 review
Physical function · patients with treating osteoarthritis
1 finding from 1 review
Adverse events Participants (n) reported adverse events · patients with treating osteoarthritis
It is very uncertain whether boswellia serrata changes adverse events Participants (n) reported adverse events compared with valdecoxib (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with treating osteoarthritis
It is very uncertain whether boswellia serrata changes adverse events Participants (n) withdrew due to adverse effects compared with valdecoxib (very low certainty).
1 finding from 1 review
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
Radiographic joint changes · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical response · Patients with collagenous colitis
Boswellia serrata extract showed no clear difference in clinical response compared with placebo (low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
Boswellia serrata extract showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with collagenous colitis
Boswellia serrata extract showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review